Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency

Gastroenterology

Volumn 152, Issue 4, 2017, Pages 821-829.e1

  Lam, Jameson R ^a   Schneider, Jennifer L ^a   Quesenberry, Charles P ^a   Corley, Douglas A ^a  

^a DIVISION OF RESEARCH   (United States)

Author keywords

Acid Suppressing; Epidemiology; Iron Deficiency; Medications

Indexed keywords

ACETYLSALICYLIC ACID; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; IRON;

ADULT; ANEMIA; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; IRON DEFICIENCY; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; AGED; CHEMICALLY INDUCED; DEFICIENCY; MALABSORPTION; MIDDLE AGED; TIME FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; IRON; MALABSORPTION SYNDROMES; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; TIME FACTORS;

EID: 85014412432     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.11.023     Document Type: Article

References (28)

1. 1 Looker, A.C., Dallman, P.R., Carroll, M.D., et al. Prevalence of iron deficiency in the United States. JAMA 277 (1997), 973–976.
2. 2 Iron deficiency—United States, 1999-2000. MMWR Morb Mortal Wkly Rep 51 (2002), 897–899.
3. 3 Declining Medicine Use and Costs: For Better or Worse? A Review of the Use of Medicines in the United States in 2012, 2013, IMS Institute for Healthcare Informatics, Burlington, MA.
4. 4 Bezwoda, W., Charlton, R., Bothwell, T., et al. The importance of gastric hydrochloric acid in the absorption of nonheme food iron. J Lab Clin Med 92 (1978), 108–116.
5. 5 Schade, S.G., Cohen, R.J., Conrad, M.E., Effect of hydrochloric acid on iron absorption. The New England journal of medicine 279 (1968), 672–674.
6. 6 Golubov, J., Flanagan, P., Adams, P., Inhibition of iron absorption by omeprazole in rat model. Dig Dis Sci 36 (1991), 405–408.
7. 7 Hutchinson, C., Geissler, C.A., Powell, J.J., et al. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut 56 (2007), 1291–1295.
8. 8 Koop, H., Bachem, M.G., Serum iron, ferritin, and vitamin B12 during prolonged omeprazole therapy. J Clin Gastroenterol 14 (1992), 288–292.
9. 9 Sarzynski, E., Puttarajappa, C., Xie, Y., et al. Association between proton pump inhibitor use and anemia: a retrospective cohort study. Dig Dis Sci 56 (2011), 2349–2353.
10. 10 Sharma, V.R., Brannon, M.A., Carloss, E.A., Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia. Southern medical journal 97 (2004), 887–889.
11. 11 Skikne, B.S., Lynch, S.R., Cook, J.D., Role of gastric acid in food iron absorption. Gastroenterology 81 (1981), 1068–1071.
12. 12 Stewart, C.A., Termanini, B., Sutliff, V.E., et al. Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy. Aliment Pharmacol Ther 12 (1998), 83–98.
13. 13 Krieger, N., Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public health 82 (1992), 703–710.
14. 14 Graham, D.J., Campen, D., Hui, R., et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 365 (2005), 475–481.
15. 15 Schatz, M., Zeiger, R.S., Vollmer, W.M., et al. Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data. J Allergy Clin Immunol 117 (2006), 995–1000.
16. 16 Lanas, A., Sekar, M.C., Hirschowitz, B.I., Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology 103 (1992), 862–869.
17. 17 Strate, L.L., Liu, Y.L., Huang, E.S., et al. Use of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleeding. Gastroenterology 140 (2011), 1427–1433.
18. 18 Pollard, J.W., Hamilton, M.J., Christensen, N.A., et al. Problems associated with long-term anticoagulant therapy. Observations in 139 cases. Circulation 25 (1962), 311–317.
19. 19 Diener, H.C., Bogousslavsky, J., Brass, L.M., et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364 (2004), 331–337.
20. 20 Kendall, B.J., Thrift, A.P., Unravelling the riddle of gastroesophageal reflux disease, obesity, and Barrett's esophagus. Clin Gastroenterol Hepatol 13 (2015), 2273–2275.
21. 21 Ioannou, G.N., Dominitz, J.A., Weiss, N.S., et al. The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia. Gastroenterology 126 (2004), 1293–1301.
22. 22 Whitfield, J.B., Zhu, G., Heath, A.C., et al. Effects of alcohol consumption on indices of iron stores and of iron stores on alcohol intake markers. Alcohol Clin Exp Res 25 (2001), 1037–1045.
23. 23 Rothman, K.J., Greenland, S., Lash, T.L., Modern epidemiology. 2008, Wolters Kluwer Health / Lippincott Williams & Wilkins, Philadelphia.
24. 24 Hosmer, D.W., Lemeshow, S., Applied Logistic Regression. 2000, Wiley, New York.
25. 25 Kleinbaum, D.G., Kupper, L.L., Morgenstern, H., Epidemiologic Research: Principles and Quantitative Methods. 1982, Lifetime Learning Publications, Belmont, CA.
26. 26 Breslow, N.E., Day, N.E., Statistical Methods in Cancer Research. Volume I - The Analysis of Case-Control Studies. 1980, IARC Scientific Publishing, Lyon, France, 5–338.
27. 27 Ajani, U.A., Ford, E.S., Greenland, K.J., et al. Aspirin use among U.S. adults: Behavioral Risk Factor Surveillance System. Am J Prev Med 30 (2006), 74–77.
28. 28 M'Rabet-Bensalah, K., Aubert, C.E., Coslovsky, M., et al. Thyroid dysfunction and anaemia in a large population-based study. Clin Endocrinol 84 (2016), 627–631.